Cancer risk among users of neuroleptic medication: a population-based cohort study.
about
Identification of novel p53 pathway activating small-molecule compounds reveals unexpected similarities with known therapeutic agentsCancer in patients with schizophrenia: What is the next step?Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability.Penfluridol suppresses glioblastoma tumor growth by Akt-mediated inhibition of GLI1.Psychiatric disorder as a risk factor for cancer: different analytic strategies produce different findings.Antidepressant use and colorectal cancer risk: a Danish population-based case-control studyPhysical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Central registry in psychiatry: A structured review.Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesisInequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study.Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis.Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis.Secondary effects of antipsychotics: women at greater risk than men.Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.Adverse effects of prolactin in rodents and humans: breast and prostate cancer.Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.Schizophrenia: women bear a disproportionate toll of antipsychotic side effects.Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?The effect of study design on the reporting of mortality due to colorectal cancer in adults with mental illness in Nova Scotia.Lithium and renal and upper urinary tract tumors - results from a nationwide population-based study.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.CHRFAM7A: a human-specific α7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPSLow-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis.Escitalopram oxalate inhibits proliferation and migration and induces apoptosis in non-small cell lung cancer cells.The use of atypical antipsychotics and the risk of breast cancer.The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosisGlioma in Schizophrenia: Is the Risk Higher or Lower?Schizophrenia: The Epidemiological Horizon
P2860
Q27318801-842C0689-EED9-4ED2-98C2-33C24247945FQ30249107-4BD3CB1D-6B35-4862-927E-002CE83033D7Q33766947-1EA764DC-2836-4220-AB16-F26248207D79Q33779323-79D24229-53BD-465F-84A0-F0C195F6285CQ34251665-5E0D18DB-CF97-48FF-8624-35AD394FAF9DQ34577531-3D3CE4D7-B4B8-49D8-ABBF-B95EB60DFAA8Q34623350-1C7A59ED-C145-4B5E-BAAD-BF8124A5CB90Q34665317-D56452D4-BB66-4670-8BB1-3E94F96E515BQ35141115-ECD6F6EF-8FBA-4809-AFCE-DE1B8426736EQ35144224-EC7A84C0-D972-4F6D-9D24-0528640E44A2Q36561220-E9878B68-D6C7-4B17-A963-062C6291689DQ36586118-14729772-CD64-4A5E-9867-7945B78539D1Q36621051-53647D17-B84A-4E19-BE4A-754DFF281725Q36910801-EE8FD2E1-A365-4187-B791-92BDCAC7FAD4Q37133664-01069E50-8016-4B66-9E58-8CADE16541F3Q37162791-A76A2029-F1B0-43E7-8496-B3611AA38884Q37246047-29DF24BA-0550-46BC-AD6A-0AC385DF269EQ37747570-84DBF0DD-7C9E-4FCC-8321-E6C8208737C6Q37887304-3335F940-EA9D-4EFE-87AF-31D777CC57B1Q38015698-9C9C9983-01CA-4808-8890-A092297494A2Q38017429-02EBD1AD-4D31-4FD5-9475-5EB7030D4694Q38411525-4BE3C8DB-E7BE-4530-A401-54D15B597655Q38538492-1D270079-4C13-47AD-8890-656F75A03774Q38598715-8C5A9D5F-8DA6-40D2-8062-68B54263BEBBQ39509938-6CE974AA-1695-482D-95E3-DC404CCB24F4Q44786818-84BEAC81-E875-4045-AAE5-43E2A9702B9BQ49494705-3249AD17-29D5-4AA3-AB49-546A2F946537Q51478587-D3E1209B-59FB-4168-B9A1-6AEB6143FB58Q58695474-89F05429-D494-449B-BAF8-D8ED2E942FD0Q58767549-D32EE72D-88C3-4DAF-878D-1F2445BE7B89Q59117302-15C18A68-F102-4F73-BCD1-0D6F50EF8F54
P2860
Cancer risk among users of neuroleptic medication: a population-based cohort study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Cancer risk among users of neuroleptic medication: a population-based cohort study.
@ast
Cancer risk among users of neuroleptic medication: a population-based cohort study.
@en
type
label
Cancer risk among users of neuroleptic medication: a population-based cohort study.
@ast
Cancer risk among users of neuroleptic medication: a population-based cohort study.
@en
prefLabel
Cancer risk among users of neuroleptic medication: a population-based cohort study.
@ast
Cancer risk among users of neuroleptic medication: a population-based cohort study.
@en
P2093
P2860
P50
P356
P1476
Cancer risk among users of neuroleptic medication: a population-based cohort study.
@en
P2093
H T Sørensen
M Nørgaard
P B Mortensen
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603259
P407
P577
2006-08-22T00:00:00Z